Sector
PharmaceuticalsOpen
₹91.9Prev. Close
₹87.73Turnover(Lac.)
₹2.79Day's High
₹91.9Day's Low
₹86.5752 Week's High
₹129.0752 Week's Low
₹66.12Book Value
₹-67.79Face Value
₹10Mkt Cap (₹ Cr.)
189.99P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 21.56 | 21.56 | 21.56 | 23.79 |
Preference Capital | 130 | 130 | 130 | 30 |
Reserves | -140.78 | -121.02 | -96.65 | -66.52 |
Net Worth | 10.78 | 30.54 | 54.91 | -12.73 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 53.7 | 33.41 | 33.77 | 3.25 |
yoy growth (%) | 60.72 | -1.08 | 937.63 | 152.43 |
Raw materials | -25.94 | -15.85 | -12.7 | -0.92 |
As % of sales | 48.31 | 47.46 | 37.61 | 28.35 |
Employee costs | -15.82 | -15.08 | -11.48 | -5.62 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -28.35 | -28.87 | -16.61 | -15.64 |
Depreciation | -5.12 | -4.67 | -4.14 | -4.23 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 7.39 | -3.08 | -6.51 | 0.9 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 60.72 | -1.08 | 937.63 | 152.43 |
Op profit growth | -5.65 | 148.34 | -6.22 | -35.49 |
EBIT growth | -3.76 | 100.46 | -5.86 | -23.33 |
Net profit growth | -1.77 | 61.97 | 11.06 | -1.66 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
G V L Prasad
Chairman (Non-Executive)
R T Ravi
Non Executive Director
Avinash Ravi
Independent Director
Tangirala Malati
Independent Director
Satish Khivsara
Independent Director
Raj Kamal Prasad Verma
Managing Director & CEO
Jitendra Shah
Company Sec. & Compli. Officer
Keyur Doshi
Additional Director
Popatlal M Kathariya
Additional Director
Dipti Shah
Additional Director
SATYA CHIGURUPATI
Additional Director
Sumanth Karlapudi
Kothapalli(V) Kasimkota(M),
Anakapalli,
Andhra Pradesh - 531031
Tel: 91-040-6680 8040
Website: http://www.krebsbiochem.com
Email: [email protected]; avinashr@krebsbiochem.
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: [email protected]
Summary
Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process...
Read More
Reports by Krebs Biochemicals & Industries Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.